Vuno signs R&D deal with Mayo Clinic for precision oncology

By AuntMinnie.com staff writers

April 22, 2022 -- South Korean artificial intelligence (AI) software developer Vuno has signed a research and development agreement with Mayo Clinic in which the parties will work together to develop AI for precision oncology.

Vuno and Mayo Clinic will work together to develop AI and machine-learning algorithms that will enable more precise diagnosis, prognosis, and treatment stratification for patients with cancer. The partners plan to develop prognostic biomarkers that will aid in therapeutic decisions and improve the quality of cancer patient care.


Copyright © 2022 AuntMinnie.com
 
Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: